Jagsonpal Pharmaceuticals (India) Market Value

JAGSNPHARM   636.65  9.80  1.52%   
Jagsonpal Pharmaceuticals' market value is the price at which a share of Jagsonpal Pharmaceuticals trades on a public exchange. It measures the collective expectations of Jagsonpal Pharmaceuticals Limited investors about its performance. Jagsonpal Pharmaceuticals is trading at 636.65 as of the 25th of December 2024. This is a 1.52 percent decrease since the beginning of the trading day. The stock's open price was 646.45.
With this module, you can estimate the performance of a buy and hold strategy of Jagsonpal Pharmaceuticals Limited and determine expected loss or profit from investing in Jagsonpal Pharmaceuticals over a given investment horizon. Check out Jagsonpal Pharmaceuticals Correlation, Jagsonpal Pharmaceuticals Volatility and Jagsonpal Pharmaceuticals Alpha and Beta module to complement your research on Jagsonpal Pharmaceuticals.
Symbol

Please note, there is a significant difference between Jagsonpal Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Jagsonpal Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Jagsonpal Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Jagsonpal Pharmaceuticals 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Jagsonpal Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Jagsonpal Pharmaceuticals.
0.00
10/26/2024
No Change 0.00  0.0 
In 2 months and 2 days
12/25/2024
0.00
If you would invest  0.00  in Jagsonpal Pharmaceuticals on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Jagsonpal Pharmaceuticals Limited or generate 0.0% return on investment in Jagsonpal Pharmaceuticals over 60 days. Jagsonpal Pharmaceuticals is related to or competes with Reliance Industries, Tata Consultancy, HDFC Bank, and Bharti Airtel. Jagsonpal Pharmaceuticals is entity of India More

Jagsonpal Pharmaceuticals Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Jagsonpal Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Jagsonpal Pharmaceuticals Limited upside and downside potential and time the market with a certain degree of confidence.

Jagsonpal Pharmaceuticals Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Jagsonpal Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Jagsonpal Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Jagsonpal Pharmaceuticals historical prices to predict the future Jagsonpal Pharmaceuticals' volatility.
Hype
Prediction
LowEstimatedHigh
572.99654.59658.86
Details
Intrinsic
Valuation
LowRealHigh
572.99757.61761.88
Details

Jagsonpal Pharmaceuticals Backtested Returns

Jagsonpal Pharmaceuticals appears to be very steady, given 3 months investment horizon. Jagsonpal Pharmaceuticals holds Efficiency (Sharpe) Ratio of 0.18, which attests that the entity had a 0.18% return per unit of risk over the last 3 months. By evaluating Jagsonpal Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.78% is justified by implied risk. Please utilize Jagsonpal Pharmaceuticals' Downside Deviation of 3.07, risk adjusted performance of 0.1527, and Market Risk Adjusted Performance of 0.766 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Jagsonpal Pharmaceuticals holds a performance score of 14. The company retains a Market Volatility (i.e., Beta) of 0.98, which attests to possible diversification benefits within a given portfolio. Jagsonpal Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Jagsonpal Pharmaceuticals is expected to follow. Please check Jagsonpal Pharmaceuticals' potential upside, and the relationship between the total risk alpha and kurtosis , to make a quick decision on whether Jagsonpal Pharmaceuticals' current trending patterns will revert.

Auto-correlation

    
  -0.05  

Very weak reverse predictability

Jagsonpal Pharmaceuticals Limited has very weak reverse predictability. Overlapping area represents the amount of predictability between Jagsonpal Pharmaceuticals time series from 26th of October 2024 to 25th of November 2024 and 25th of November 2024 to 25th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Jagsonpal Pharmaceuticals price movement. The serial correlation of -0.05 indicates that only as little as 5.0% of current Jagsonpal Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient-0.05
Spearman Rank Test-0.19
Residual Average0.0
Price Variance622.99

Jagsonpal Pharmaceuticals lagged returns against current returns

Autocorrelation, which is Jagsonpal Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Jagsonpal Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Jagsonpal Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Jagsonpal Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Jagsonpal Pharmaceuticals regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Jagsonpal Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Jagsonpal Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Jagsonpal Pharmaceuticals stock over time.
   Current vs Lagged Prices   
       Timeline  

Jagsonpal Pharmaceuticals Lagged Returns

When evaluating Jagsonpal Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Jagsonpal Pharmaceuticals stock have on its future price. Jagsonpal Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Jagsonpal Pharmaceuticals autocorrelation shows the relationship between Jagsonpal Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Jagsonpal Pharmaceuticals Limited.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Jagsonpal Stock

Jagsonpal Pharmaceuticals financial ratios help investors to determine whether Jagsonpal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jagsonpal with respect to the benefits of owning Jagsonpal Pharmaceuticals security.